[Graft-versus-host disease after organ transplantation: donor and host factors]

E Kobayashi1

  • 1Department of Clinical Pharmacology, Jichi Medical School, Tochigi, Japan.

Graft-versus-host disease (GVHD) induced by organ transplantation is dependent on both the quality and quantity of lymphocytes included in the graft. Changes in the host immune function after surgery are also important factors in the development of this disease. Based on our experimental data, GVHD after organ transplantation is reviewed To test the reactivity of graft lymphocytes in in vivo, small bowel, liver pancreas/spleen, and heart/lung transplantations were performed using a rat in parent-to-F 1 hybrid combination. All of the lymphoid organ transplants induced lethal GVHD, while liver graft did not accelerated the disease after the transplantation procedure. Lymphocytes in liver grafts had a unique population and showed a low response against alloantigens in vivo. Surgical treatments also increased the susceptibility to GVHD, especially the ischemic-reperfusion procedure; Endogenous endotoxemia triggered by reperfusion promoted the development of lethal GVHD.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...